2
Introduction
➤ Allergic rhinitis (AR) and allergic asthma (AA) are caused by an
immunoglobulin E (IgE) mediated inflammatory response to proteins
(or glycoproteins) carried by inhaled organic particles such as pollen,
animal dander, mold spores, and/or mite/insect debris.
➤ Inhalant allergies can be treated by immunotherapy, pharmaceuticals,
or by reducing environmental exposure to the allergen.
➤ Inhalant allergen immunotherapy (AIT) is administered to millions of
patients for AR and AA and is most commonly delivered as subcutaneous
immunotherapy (SCIT) or sublingual immunotherapy (SLIT).
➤ Variability in the initiation and delivery of safe and effective
immunotherapy provides opportunities for evidence-based
recommendations to improve patient care.
